Pfizer Opens Study Of Omicron-Specific COVID-19 Vaccine
Pfizer Opens Study Of Omicron-Specific COVID-19 Vaccine

The drugmaker and partner BioNTech will begin clinical trials on a new vaccine developed to protect against the more contagious variant.